resveratrol has been researched along with Fibroid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Changou, CA; Chen, YR; Chin, YT; Chou, SY; Davis, PJ; Ho, Y; Lin, HY; Lin, SJ; Liu, HL; Sh Yang, YC; Shih, YJ; Tang, HY; Whang-Peng, J | 1 |
Chang, YC; Kim, CH; Kim, DI; Lee, DK; Lee, TK; Lee, YC | 1 |
2 other study(ies) available for resveratrol and Fibroid
Article | Year |
---|---|
Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin αvβ3 and IGF-1R.
Topics: Cell Proliferation; Female; Flow Cytometry; Humans; In Situ Nick-End Labeling; Integrin alphaVbeta3; Leiomyoma; Phosphorylation; Receptor Cross-Talk; Receptor, IGF Type 1; Resveratrol; Stilbenes; Uterine Neoplasms | 2018 |
Inhibitory effects of Scutellaria barbata D. Don on human uterine leiomyomal smooth muscle cell proliferation through cell cycle analysis.
Topics: Antineoplastic Agents; Berberine; Blotting, Western; Cell Cycle; Cell Proliferation; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Flavonoids; Flow Cytometry; Humans; Leiomyoma; Myocytes, Smooth Muscle; Myometrium; Plant Extracts; Plant Stems; Resveratrol; Scutellaria; Stilbenes; Tumor Cells, Cultured; Uterine Neoplasms | 2004 |